These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 9183449)
41. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306 [TBL] [Abstract][Full Text] [Related]
42. Cerebrospinal fluid and metastasis of transitional cell carcinoma of the bladder. Hust MH; Pfitzer P Acta Cytol; 1982; 26(2):217-23. PubMed ID: 6952725 [TBL] [Abstract][Full Text] [Related]
43. Application of intrathecal trastuzumab (Herceptintrade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer. Stemmler HJ; Schmitt M; Harbeck N; Willems A; Bernhard H; Lässig D; Schoenberg S; Heinemann V Oncol Rep; 2006 May; 15(5):1373-7. PubMed ID: 16596213 [TBL] [Abstract][Full Text] [Related]
44. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy. Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485 [TBL] [Abstract][Full Text] [Related]
45. Cutaneous metastases from transitional cell carcinoma of the bladder. Block CA; Dahmoush L; Konety BR Urology; 2006 Apr; 67(4):846.e15-7. PubMed ID: 16600346 [TBL] [Abstract][Full Text] [Related]
46. Complex partial status epilepticus in a patient with dural metastases. Steg RE; Frank AR; Lefkowitz DM Neurology; 1993 Nov; 43(11):2389-92. PubMed ID: 8232965 [TBL] [Abstract][Full Text] [Related]
47. Robot-assisted radical cystectomy with intracorporeal urinary diversion in patients with transitional cell carcinoma of the bladder. Jonsson MN; Adding LC; Hosseini A; Schumacher MC; Volz D; Nilsson A; Carlsson S; Wiklund NP Eur Urol; 2011 Nov; 60(5):1066-73. PubMed ID: 21852033 [TBL] [Abstract][Full Text] [Related]
48. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies. Zhang M; Tao R; Zhang C; Shen Z Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377 [TBL] [Abstract][Full Text] [Related]
49. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists. Lancet; 1999 Aug; 354(9178):533-40. PubMed ID: 10470696 [TBL] [Abstract][Full Text] [Related]
50. [Meningeal carcinomatosis]. Baiges-Octavio JJ; Huerta-Villanueva M Rev Neurol; 2000 Dec 16-31; 31(12):1237-41. PubMed ID: 11205566 [TBL] [Abstract][Full Text] [Related]
51. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy]. Sahwi A; Robert M; Delbos O; Legouffe E; Guiter J; Navratil H Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259 [TBL] [Abstract][Full Text] [Related]
52. [Study of meningeal carcinomatosis: diagnosis and treatment]. Nakagawa H; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Kubo S; Hayakawa T No Shinkei Geka; 1992 Jan; 20(1):31-7. PubMed ID: 1738424 [TBL] [Abstract][Full Text] [Related]
54. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience. Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803 [TBL] [Abstract][Full Text] [Related]
55. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118 [TBL] [Abstract][Full Text] [Related]
56. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report. Stemmler HJ; Mengele K; Schmitt M; Harbeck N; Laessig D; Herrmann KA; Schaffer P; Heinemann V Anticancer Drugs; 2008 Sep; 19(8):832-6. PubMed ID: 18690096 [TBL] [Abstract][Full Text] [Related]
57. Cheek metastasis from a bladder tumor: unusual presentation of an aggressive disease. Kumar Goyal N; Goel A; Sankhwar SN; Mandal S; Singhai A; Singh S Urologia; 2013; 80(4):317-21. PubMed ID: 23813285 [TBL] [Abstract][Full Text] [Related]
58. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy. Soloway MS; Lopez AE; Patel J; Lu Y Cancer; 1994 Apr; 73(7):1926-31. PubMed ID: 8137219 [TBL] [Abstract][Full Text] [Related]
59. A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy. Baumann BC; Guzzo TJ; He J; Keefe SM; Tucker K; Bekelman JE; Hwang WT; Vaughn DJ; Malkowicz SB; Christodouleas JP Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):81-8. PubMed ID: 22543204 [TBL] [Abstract][Full Text] [Related]
60. Meningeal carcinomatosis due to basal cell carcinoma. Soffer D; Kaplan H; Weshler Z Hum Pathol; 1985 May; 16(5):530-2. PubMed ID: 3988279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]